Delivery Order #SPE2DB26FWRN7

Short-Term Delivery Order for Vyvanse Capsules under AmerisourceBergen IDIQ

This award is a delivery order contract issued to AmerisourceBergen Drug Corporation, a leading pharmaceutical sourcing and distribution company in the United States. The procurement involves the supply of Vyvanse 30 mg capsules, a specific pharmaceutical product. The contract is part of a larger indefinite delivery, indefinite quantity (IDIQ) agreement that enables flexible and timely ordering of pharmaceutical products to support the agency's healthcare operations. The delivery order signifies a focused, short-term task fulfillment within a substantial ongoing IDIQ contract aimed at ensuring the availability of critical medications. Work under this order encompasses the acquisition and delivery of Vyvanse capsules to a designated location in Conshohocken, Pennsylvania, within a narrow timeframe. This contract was awarded following the terms established in the parent IDIQ agreement, which was competitively procured to enhance pharmaceutical supply chain responsiveness. The delivery order represents a multi-day engagement slated for completion within October 2025, complementing the broader multi-year IDIQ contract that runs through the end of 2025 with potential extensions. No key subcontractors or original solicitation details were specified for this delivery order.

Description

4571814451!VYVANSE 30 MG CAPSULE 100S

View original record